/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Michelle Melisko

University of California, San Francisco(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

338

Papers

11.3K

Citations

52

h-index

131

i10-index

Michelle Melisko is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Breast Cancer Treatment Studies & Cancer survivorship and care. The author has an h-index of 52, co-authored 288 publications.

ORCID: 0000-0002-8729-4667

Research Topics

Cancer Treatment and Pharmacology Breast Cancer Treatment Studies Cancer survivorship and care HER2/EGFR in Cancer Research Brain Metastases and Treatment

Papers by this author

works

Adaptive Randomization of Neratinib in Early Breast Cancer

2016 · New England Journal of Medicine · 456 citations

https://doi.org/10.1056/nejmoa1513750

John W. Park Minetta C. Liu Douglas Yee Christina Yau

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

2021 · Cancer Cell · 308 citations

https://doi.org/10.1016/j.ccell.2021.05.009

Lajos Pusztai Christina Yau Denise M. Wolf Hyo S. Han

Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial

2019 · Clinical Cancer Research · 206 citations

https://doi.org/10.1158/1078-0432.ccr-18-2867

Elizabeth A. Mittendorf Biao Lu Michelle Melisko Julie Price Hiller

Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

2016 · Journal of Clinical Oncology · 167 citations

https://doi.org/10.1200/jco.2015.63.0343

Rachel A. Freedman Rebecca Gelman Jeffrey S. Wefel Michelle Melisko

Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy

2014 · Cancer · 119 citations

https://doi.org/10.1002/cncr.28699

Christine Miaskowski Bruce A. Cooper Michelle Melisko Lee-may Chen

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial

2020 · Journal of Clinical Oncology · 108 citations

https://doi.org/10.1200/jco.19.01027

A. Jo Chien Debasish Tripathy Kathy S. Albain W. Fraser Symmans

Research topics

topics

Cancer Treatment and Pharmacology

Breast Cancer Treatment Studies

Cancer survivorship and care

HER2/EGFR in Cancer Research

Brain Metastases and Treatment

Chat about Author

Papers

Chat

Click to start Chat